Virtual Event Information
Join Sinclair Research on Thursday, November 11th, 2021 for this Talking Tox Webinar at ACT’s annual meeting.
“Choosing the Right Model: Miniature Swine Model Selection Criteria for Toxicology and Pharmacology Studies”
Several different miniature swine models are commonly used as a second species in nonclinical research. This presentation will focus on the scientific rationale for miniature swine model selection, special considerations for toxicology and pharmacology study parameters, and comparative data of commonly used miniature swine strains.
Dr. Scott E. Boley, PhD, DABT, has advised Sponsors on their nonclinical needs for the last 15 years and managed toxicology programs for 19 years. He has extensive expertise in drug development as well as the regulatory expectations for a variety of test article types and indications. In his role as Senior Vice President of Research, Scott oversees the Research, Report Services, and SEND groups at Sinclair Research that supports each Sponsor’s nonclinical safety programs. Scott is a diplomate of the American Board of Toxicology and holds a B.Sc. in Biochemistry and a Ph.D. in Biochemistry/Environmental Toxicology from Michigan State University.
Derek Brocksmith is the General Manager of Sinclair BioResources and has spent 13 years managing the largest production herds of minipigs for biomedical research in North America. Previous to joining Sinclair, Derek spent most of his career working in agriculture and agriculture-related fields with a focus on swine production. Derek earned bachelor’s degrees in animal science and criminal justice from National University in San Diego while serving in the United States Marine Crops.
ACT Virtual 42nd Annual Meeting
November 10-19, 2021
More information: https://www.actox.org/am/am2021/